Skip to Content
MilliporeSigma

Key Documents

View All Documentation

Skip To

HPA036900

Sigma-Aldrich

Anti-ALDH1L1 antibody produced in rabbit

enhanced validation

Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution

Synonym(s):

Anti-10-fTHF, Anti-Aldehyde dehydrogenase 1 family, member L1, Anti-FTHFD

Sign Into View Organizational & Contract Pricing

Select a Size

5 MG
15 983,00 INR
25 MG
56 848,00 INR

15 983,00 INR

Please contact Customer Service for Availability

Select a Size

Change View
5 MG
15 983,00 INR
25 MG
56 848,00 INR

About This Item

UNSPSC Code:
12352203
Human Protein Atlas Number:
HPA036900
NACRES:
NA.43

15 983,00 INR

Please contact Customer Service for Availability
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

biological source

rabbit

Quality Level

100

conjugate

unconjugated

antibody form

affinity isolated antibody

antibody product type

primary antibodies

clone

polyclonal

product line

Prestige Antibodies® Powered by Atlas Antibodies

form

buffered aqueous glycerol solution

species reactivity

human

enhanced validation

independent
Learn more about Antibody Enhanced Validation

Related Categories

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
53581-U53579-U53567-U
Ascentis® Express F5, 2.7 μm HPLC Column 2.7 μm particle size, L × I.D. 5 cm × 3 mm

53576-U

Ascentis® Express F5, 2.7 μm HPLC Column

Ascentis® Express F5, 2.7 μm HPLC Column 2.7 μm particle size, L × I.D. 3 cm × 4.6 mm

53581-U

Ascentis® Express F5, 2.7 μm HPLC Column

Ascentis® Express F5, 2.7 μm HPLC Column 2.7 μm particle size, L × I.D. 15 cm × 3 mm

53579-U

Ascentis® Express F5, 2.7 μm HPLC Column

Ascentis® Express F5, 2.7 μm HPLC Column 2.7 μm particle size, L × I.D. 5 cm × 2.1 mm

53567-U

Ascentis® Express F5, 2.7 μm HPLC Column

particle size

2.7 μm

particle size

2.7 μm

particle size

2.7 μm

particle size

2.7 μm

matrix active group

PFP (pentafluorophenyl) phase

matrix active group

PFP (pentafluorophenyl) phase

matrix active group

PFP (pentafluorophenyl) phase

matrix active group

PFP (pentafluorophenyl) phase

separation technique

reversed phase

separation technique

reversed phase

separation technique

reversed phase

separation technique

reversed phase

L × I.D.

5 cm × 3 mm

L × I.D.

3 cm × 4.6 mm

L × I.D.

15 cm × 3 mm

L × I.D.

5 cm × 2.1 mm

product line

Ascentis®

product line

Ascentis®

product line

Ascentis®

product line

Ascentis®

matrix

Fused-Core particle platform, superficially porous particle

matrix

Fused-Core particle platform, superficially porous particle

matrix

Fused-Core particle platform, superficially porous particle

matrix

Fused-Core particle platform, superficially porous particle

Immunogen

aldehyde dehydrogenase 1 family, member L1 recombinant protein epitope signature tag (PrEST)

Application

All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry.

The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. We also provide Prestige Antibodies® protocols and other useful information.

Features and Benefits

Prestige Antibodies® are highly characterized and extensively validated antibodies with the added benefit of all available characterization data for each target being accessible via the Human Protein Atlas portal linked just below the product name at the top of this page. The uniqueness and low cross-reactivity of the Prestige Antibodies® to other proteins are due to a thorough selection of antigen regions, affinity purification, and stringent selection. Prestige antigen controls are available for every corresponding Prestige Antibody and can be found in the linkage section.

Every Prestige Antibody is tested in the following ways:
  • IHC tissue array of 44 normal human tissues and 20 of the most common cancer type tissues.
  • Protein array of 364 human recombinant protein fragments.

Linkage

Corresponding Antigen APREST79397

Physical form

Solution in phosphate buffered saline, pH 7.2, containing 40% glycerol and 0.02% sodium azide.

Legal Information

Prestige Antibodies is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class Code

10 - Combustible liquids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

  • Specification Sheet

    • Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number
    R33822

    Don't see the Right Version?

    If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

    Search for a COA

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    U. Naegele et al.
    Methods of Enzymatic Analysis, 7, 140-140 (1985)
    M.H. Jensen et al.
    Methods of Enzymatic Analysis, 7, 101-101 (1985)
    Patrizia Zaramella et al.
    Pediatrics, 131(1), e309-e312 (2012-12-05)
    This case report describes a preterm newborn infant who was treated with a single dose of rasburicase for an increase in uric acid level. He died on the third day as a result of complications of hemolysis, which appeared to
    Sara Cipriani et al.
    Journal of neurochemistry, 123(1), 172-181 (2012-06-08)
    Urate is the end product of purine metabolism and a major antioxidant circulating in humans. Recent data link higher levels of urate with a reduced risk of developing Parkinson's disease and with a slower rate of its progression. In this
    Chia-Ter Chao et al.
    Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 21(5), 498-500 (2012-06-13)
    To report a case of huge hepatocellular carcinoma associated with tumor lysis syndrome and its management. A 51-year-old hepatitis B carrier visited our clinic with progressive weight loss over recent months. Abdominal ultrasonography and magnetic resonance imaging revealed a huge
    View All Related Papers

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service